NCT06305208 A UK Registry for Metabolic and Bariatric Endoscopic Interventions
| NCT ID | NCT06305208 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cleveland Clinic London |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2034-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-02-01 with a primary completion date of 2034-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the UK alone, obesity is a major health problem with more than one quarter of adults estimated to be obese. Obesity promotes the development of many serious diseases including diabetes, heart disease, kidney disease, and increased risk of some cancers. Patients living with obesity also suffer from significant symptoms that impact their life including shortness of breath, back pain, poor mobility, and poor mental health. Traditional methods to help lose weight include low calorie diets and increased exercise. These may be effective in the short-term, but due to powerful biological mechanisms they are hard to maintain over the long-term and most individuals are unable to achieve normal weight. This means many people may need bariatric surgery that is highly effective at lowering body weight, but it is associated with complications and not all patients will want or be able to undergo surgery. This has led to the development of many new obesity treatments that are completed with an endoscope. An endoscope is a thin flexible tube that has a camera at the end. It is inserted through the mouth and into the stomach and small bowel. There are various procedures that can be done at the time of endoscopy that have been shown to be effective with a low number of side-effects. These are still relatively new compared to more traditional treatments and only a small number of doctors can perform them within the UK. Due to these limitations, the aim of this registry is to obtain real-world information on the safety and effectiveness of these procedures across the UK. The investigators hope over time this will improve the knowledge of clinicians about treating obesity with endoscopy and support future access and funding to these treatments.
Eligibility Criteria
Inclusion Criteria: * Any patient undergoing a primary or revisional bariatric or metabolic endoscopic procedure. * Age ≥ 18 years old * Able to give written informed consent. Exclusion Criteria: * Any bariatric or metabolic endoscopic procedure performed outside the UK. * Any bariatric or metabolic endoscopic procedure not currently listed within the registry protocol or agreed by the steering committee. * Unable to provide written informed consent.
Contact & Investigator
Rehan Haidry, MD
PRINCIPAL INVESTIGATOR
Cleveland Clinic London
Frequently Asked Questions
Who can join the NCT06305208 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06305208 currently recruiting?
Yes, NCT06305208 is actively recruiting participants. Contact the research team at cclendoscopyresearch@ccf.org for enrollment information.
Where is the NCT06305208 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06305208 clinical trial?
NCT06305208 is sponsored by Cleveland Clinic London. The principal investigator is Rehan Haidry, MD at Cleveland Clinic London. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.